Comparison results
| Results: Differences General | ✘Transient blindness | ✘H25-H28 | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | 38% | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
| transient blindness | 37% | — | |||||||
| cataract | — | 87% | |||||||
| retinal angiospasm | 32% | — | |||||||
| s eyes cloudy | — | 82% | |||||||
| giant cell arteritis | 31% | — | |||||||
| cataract removal | — | 61% | |||||||
| rheumatic polymyalgia | 29% | — | |||||||
| senile hyperopia | — | 56% | |||||||
| rheumatic muscle pain | 29% | — | |||||||
| tension in the eyes | — | 54% | |||||||
| fundus arteries narrowed | 29% | — | |||||||
| worse at home | — | 53% | |||||||
| soft tissue rheumatism | 28% | — | |||||||
| secondary cataract | — | 53% | |||||||
| photopsia | 27% | — | |||||||
| congenital cataract | — | 52% | |||||||
| systemic vasculitis | 25% | — | |||||||
| a calm patient | — | 51% | |||||||
| vascular spasm | 24% | — | |||||||
| gray eyes | — | 50% | |||||||
| rheumatic inflammation | 24% | — | |||||||
| hyperopia | — | 49% | |||||||
| dilated pupils | 24% | — | |||||||
| shroud | — | 45% | |||||||
| thrombosis | 23% | — | |||||||
| double vision | — | 43% | |||||||
| allergy to local anesthetics | 23% | — | |||||||
| more often in old age | — | 43% | |||||||
| vitamin b3 increased | 23% | — | |||||||
| mechanical damage to the eyes | 19% | 62% | |||||||
| rheumatism | 23% | — | |||||||
| eye injury | 19% | 62% | |||||||
| up vascular mesh | 23% | — | |||||||
| immaturity | — | 42% | |||||||
| arterial occlusion | 22% | — | |||||||
| blurred vision | 12% | 54% | |||||||
| vasculitis | 22% | — | |||||||
| visual impairment | 19% | 61% | |||||||
| angiopathy of the retina | 22% | — | |||||||
| history of surgery | 19% | 60% | |||||||
| impaired arterial function | 21% | — | |||||||
| liebman-sachs endocarditis | — | 41% | |||||||
| pale optic discs | 21% | — | |||||||
| endocarditis | — | 39% | |||||||
| spasm | 21% | — | |||||||
| head injury | — | 38% | |||||||
| disease periodic muscle | 20% | — | |||||||
| consequences of taking medications | 15% | 51% | |||||||
| hypertrophy of the nasal shells | 20% | — | |||||||
| does not tolerate pain | — | 36% | |||||||
| limitation of the mobility of the eyeballs | 20% | — | |||||||
| fighting | — | 35% | |||||||
| better lying down | 19% | — | |||||||
| eye surgery | 21% | 55% | |||||||
| angiopathy | 19% | — | |||||||
| diabetes mellitus | — | 34% | |||||||
| muscle pain | 19% | — | |||||||
| impaired lung function | — | 32% | |||||||
| periodic illness | 19% | — | |||||||
| consequences of surgery | 13% | 44% | |||||||
| angioplasty | 19% | — | |||||||
| myopia | 13% | 44% | |||||||
| cotton head | 18% | — | |||||||
| trauma | 13% | 43% | |||||||
| increased | 17% | — | |||||||
| inflammation | 17% | 29% | |||||||
| blood diseases | 16% | — | |||||||
| anesthesia | 23% | 33% | |||||||
| hematoma | 16% | — | |||||||
| traumatic illness | 16% | — | |||||||
| numbness of the skin | 16% | — | |||||||
| defects of the upper jaw | 16% | — | |||||||
| it gets dark in the eyes | 16% | — | |||||||
| aura | 16% | — | |||||||
| pupils enlarged | 16% | — | |||||||
| occlusion of the central retinal vein | 16% | — | |||||||
| ptosis of the upper eyelids | 15% | — | |||||||
| changes in the blood | 15% | — | |||||||
| consequences of eye surgery | 14% | — | |||||||
| neurological disorders | 14% | — | |||||||
| acute pain | 14% | — | |||||||
| dark eyes | 13% | — | |||||||
| violation of fat metabolism | 13% | — | |||||||
| nose large eyes | 13% | — | |||||||
| peripheral artery thrombosis | 13% | — | |||||||
| skin problems | 13% | — | |||||||
| nerve damage | 12% | — | |||||||
| acceleration of movements | 12% | — | |||||||
| lowered | 12% | — | |||||||
| clear boundaries | 12% | — | |||||||
| speech slurred | 11% | — | |||||||
| pain in the eyes | 11% | — | |||||||
| constantly moving | 11% | — | |||||||
| up circulatory disorders | 10% | — | |||||||
| allergy | 10% | — | |||||||
| control issues | 10% | — | |||||||
| wound | 10% | — | |||||||
| subacute condition | 10% | — | |||||||
| CHD | 10% | — | |||||||
| heart dysfunction | 9% | — | |||||||
| swelling | 9% | — | |||||||
| drug disease | 9% | — | |||||||
Instructions
Video
|